Dysfunctional Autophagy, Proteostasis, and Mitochondria as a Prelude to Age-Related Macular Degeneration
- PMID: 37240109
- PMCID: PMC10217992
- DOI: 10.3390/ijms24108763
Dysfunctional Autophagy, Proteostasis, and Mitochondria as a Prelude to Age-Related Macular Degeneration
Abstract
Retinal pigment epithelial (RPE) cell dysfunction is a key driving force of AMD. RPE cells form a metabolic interface between photoreceptors and choriocapillaris, performing essential functions for retinal homeostasis. Through their multiple functions, RPE cells are constantly exposed to oxidative stress, which leads to the accumulation of damaged proteins, lipids, nucleic acids, and cellular organelles, including mitochondria. As miniature chemical engines of the cell, self-replicating mitochondria are heavily implicated in the aging process through a variety of mechanisms. In the eye, mitochondrial dysfunction is strongly associated with several diseases, including age-related macular degeneration (AMD), which is a leading cause of irreversible vision loss in millions of people globally. Aged mitochondria exhibit decreased rates of oxidative phosphorylation, increased reactive oxygen species (ROS) generation, and increased numbers of mitochondrial DNA mutations. Mitochondrial bioenergetics and autophagy decline during aging because of insufficient free radical scavenger systems, the impairment of DNA repair mechanisms, and reductions in mitochondrial turnover. Recent research has uncovered a much more complex role of mitochondrial function and cytosolic protein translation and proteostasis in AMD pathogenesis. The coupling of autophagy and mitochondrial apoptosis modulates the proteostasis and aging processes. This review aims to summarise and provide a perspective on (i) the current evidence of autophagy, proteostasis, and mitochondrial dysfunction in dry AMD; (ii) current in vitro and in vivo disease models relevant to assessing mitochondrial dysfunction in AMD, and their utility in drug screening; and (iii) ongoing clinical trials targeting mitochondrial dysfunction for AMD therapeutics.
Keywords: age-related macular degeneration; aging; autophagy; clinical trials; mitochondrial dysfunction; retinal pigment epithelium.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration.Prog Retin Eye Res. 2020 Nov;79:100858. doi: 10.1016/j.preteyeres.2020.100858. Epub 2020 Apr 13. Prog Retin Eye Res. 2020. PMID: 32298788 Free PMC article. Review.
-
Loss of NRF-2 and PGC-1α genes leads to retinal pigment epithelium damage resembling dry age-related macular degeneration.Redox Biol. 2019 Jan;20:1-12. doi: 10.1016/j.redox.2018.09.011. Epub 2018 Sep 14. Redox Biol. 2019. PMID: 30253279 Free PMC article.
-
Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.Stem Cell Res Ther. 2022 Jun 17;13(1):260. doi: 10.1186/s13287-022-02937-6. Stem Cell Res Ther. 2022. PMID: 35715869 Free PMC article.
-
Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration.Cell Death Dis. 2017 Jan 5;8(1):e2537. doi: 10.1038/cddis.2016.453. Cell Death Dis. 2017. PMID: 28055007 Free PMC article.
-
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment.Expert Opin Ther Targets. 2020 Apr;24(4):359-378. doi: 10.1080/14728222.2020.1737015. Epub 2020 Mar 2. Expert Opin Ther Targets. 2020. PMID: 32116056 Review.
Cited by
-
Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.Int J Mol Sci. 2025 Jun 25;26(13):6112. doi: 10.3390/ijms26136112. Int J Mol Sci. 2025. PMID: 40649894 Free PMC article. Review.
-
Features that distinguish age-related macular degeneration from aging.Exp Eye Res. 2025 May;254:110303. doi: 10.1016/j.exer.2025.110303. Epub 2025 Feb 20. Exp Eye Res. 2025. PMID: 39986366 Free PMC article. Review.
-
The effects of time restricted feeding on age-related changes in the mouse retina.Exp Gerontol. 2024 Sep;194:112510. doi: 10.1016/j.exger.2024.112510. Epub 2024 Jul 5. Exp Gerontol. 2024. PMID: 38964431 Free PMC article.
-
RPE melanin and its influence on the progression of AMD.Ageing Res Rev. 2024 Aug;99:102358. doi: 10.1016/j.arr.2024.102358. Epub 2024 Jun 1. Ageing Res Rev. 2024. PMID: 38830546 Free PMC article. Review.
-
Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.Adv Sci (Weinh). 2024 Aug;11(32):e2403399. doi: 10.1002/advs.202403399. Epub 2024 Jun 21. Adv Sci (Weinh). 2024. PMID: 39031809 Free PMC article. Review.
References
-
- Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health. 2014;2:e106–e116. doi: 10.1016/S2214-109X(13)70145-1. - DOI - PubMed
-
- Spaide R.F., Jaffe G.J., Sarraf D., Freund K.B., Sadda S.R., Staurenghi G., Waheed N.K., Chakravarthy U., Rosenfeld P.J., Holz F.G., et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology. 2020;127:616–636. doi: 10.1016/j.ophtha.2019.11.004. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials